Brooklands Fund Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Brooklands Fund Management's ELV Position: Q2 2026 in Review
Brooklands Fund Management reduced its Elevance Health (ELV) stake by 0.02% in Q2 2026, selling an estimated $1.85K and leaving 21,102 shares worth $8.84M. The position accounts for 6.91% of the portfolio, ranked #3.
Brooklands Fund Management first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Brooklands Fund Management held 21,102 shares of Elevance Health worth $8.84M as of Q2 2026.
- Brooklands Fund Management sold 5 Elevance Health shares in Q2 2026, an estimated $1.85K.
- Elevance Health made up 6.91% of Brooklands Fund Management's portfolio in Q2 2026, its #3 holding.
- Brooklands Fund Management first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Brooklands Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.